Cencora, Inc.

COR NYSE CIK: 0001140859

Company Information

Industry Wholesale-Drugs, Proprietaries & Druggists' Sundries
SIC Code 5122
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation DE
Business Address 1 WEST FIRST AVENUE, CONSHOHOCKEN, PA, 19428
Mailing Address 1 WEST FIRST AVENUE, CONSHOHOCKEN, PA, 19428
Phone 610-727-7000
Fiscal Year End 0930
EIN 233079390

Financial Overview

FY2025 FY

$321.33B
Revenue
$1.55B
Net Income
$645.94M
Stockholders' Equity
$8.62
EPS

Recent SEC Filings

Form Type Date Filed Document
SCHEDULE 13G/A Passive ownership amendment March 26, 2026 View on SEC
8-K Current report of material events March 23, 2026 View on SEC
8-K Current report of material events March 17, 2026 View on SEC
4 Insider stock transaction report March 13, 2026 View on SEC
4 Insider stock transaction report March 13, 2026 View on SEC
4 Insider stock transaction report March 13, 2026 View on SEC
4 Insider stock transaction report March 9, 2026 View on SEC
4 Insider stock transaction report March 9, 2026 View on SEC
4 Insider stock transaction report March 9, 2026 View on SEC
4 Insider stock transaction report March 9, 2026 View on SEC

Annual Reports

10-K November 25, 2025
  • Achieved $260 billion in sales for fiscal year 2025, a 7% increase from the previous year.
  • Acquired Retina Consultants of America (RCA) on January 2, 2025, with $100 million in potential future payments.
View Analysis

Material Events

8-K Acquisition March 23, 2026
High Impact
  • Cencora is acquiring EyeSouth Partners' retina business, marking an expansion into direct patient care.
  • This strategic move diversifies Cencora into a high-growth, specialized healthcare market beyond drug distribution.
View Analysis
8-K Acquisition February 18, 2026
High Impact
  • Cencora strategically merges MWI Animal Health with Covetrus, valued at $3.5 billion.
  • Cencora receives $1.25 billion in cash upfront and a $2.25 billion equity stake in the combined entity.
View Analysis

Insider Trading

STRONG SELL 4 insiders 7 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 5122)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.